Related Experiment Video

Updated: Jul 11, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

Targeting PGC-1 alpha to control energy homeostasis

Zhidan Wu1, Olivier Boss

  • 1Novartis Institutes for BioMedical Research, Inc., 100 Technology Square, Cambridge, MA 02139, USA. zhidan.wu@novartis.com

Expert Opinion on Therapeutic Targets
|October 3, 2007
PubMed

Insights

Type 2 diabetes is rising globally. Targeting mitochondrial function via PGC-1alpha activation offers a promising therapeutic strategy for metabolic diseases like diabetes.

Area of Science:

  • Metabolic diseases
  • Mitochondrial biology
  • Diabetes research

Background:

  • Rising global prevalence of Type 2 diabetes necessitates novel therapeutic approaches.
  • Impaired mitochondrial function is implicated in the pathogenesis of insulin resistance and Type 2 diabetes.
  • Peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC-1alpha) is a key regulator of mitochondrial biogenesis and energy metabolism.

Purpose of the Study:

  • To explore the therapeutic potential of targeting PGC-1alpha for Type 2 diabetes.
  • To investigate the role of PGC-1alpha in mitochondrial dysfunction associated with metabolic diseases.

Main Methods:

  • Review of recent evidence on mitochondrial function and PGC-1alpha in diabetes.
  • Analysis of regulatory proteins affecting PGC-1alpha transcription and activity.

Main Results:

  • Impaired mitochondrial function is a key factor in Type 2 diabetes pathogenesis.
  • PGC-1alpha activation can potentially restore mitochondrial function and oxidative capacity.
  • Several proteins regulating PGC-1alpha are identified as potential pharmaceutical targets.

Conclusions:

  • Activation of PGC-1alpha presents a viable strategy for developing new treatments for Type 2 diabetes.
  • Targeting proteins that modulate PGC-1alpha offers a promising avenue for pharmaceutical intervention in metabolic diseases.

More Related Videos

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...